Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,733 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,059 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00174616 | CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision | completed | Phase 2 | 87 | SanofiINDUSTRY | 7 | Dec 7, 2009 | clinicaltrials |
| NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00020930 |
| completed |
| Phase 2 |
| — |
| Memorial Sloan Kettering Cancer CenterOTHER |
| 1 |
| Dec 4, 2009 |
| clinicaltrials |
| NCT00380588 | Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00681252 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681330 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681421 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681577 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00344552 | Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00125021 | Tarceva and Capecitabine for Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00165568 | Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT01002443 | Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer | completed | Phase 2 | 190 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 27, 2009 | clinicaltrials |
| NCT00399750 | TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer | completed | Phase 2 | 373 | SanofiINDUSTRY | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00990535 | High Dose Somatostatin Analogues in Neuroendocrine Tumors(HIDONET) | completed | Phase 2 | 28 | Federico II UniversityOTHER | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00320515 | Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 89 | Eli Lilly and CompanyINDUSTRY | 4 | Sep 28, 2009 | clinicaltrials |
| NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | completed | Phase 2 | 110 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00980382 | A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma | completed | Phase 1 / Phase 2 | 85 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 21, 2009 | clinicaltrials |
| NCT00263029 | Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer(PROCTFUL) | completed | Phase 2 | 18 | SanofiINDUSTRY | 0 | Sep 18, 2009 | clinicaltrials |
| NCT00512681 | A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer(TIROX2) | completed | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)(ABX067) | completed | Phase 2 | 29 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00327119 | Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Sep 14, 2009 | clinicaltrials |
| NCT00063427 | Study Evaluating MAC-321 in Colorectal Cancer | completed | Phase 2 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00072748 | Study Evaluating EKB-569 in Advanced Colorectal Cancer | completed | Phase 2 | 63 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00330915 | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00350753 | Avastin and Tarceva for Upper Gastrointestinal Cancers | completed | Phase 2 | 126 | Rigshospitalet, DenmarkOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00936572 | Probiotics In Colorectal Cancer Patients | completed | Phase 2 | 35 | University of Milano BicoccaOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00464919 | Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00531245 | A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 77 | Samsung Medical CenterOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00919282 | Gemcitabine (GFF) in Patients With Pancreatic Cancer(GFF) | completed | Phase 2 | 78 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00919659 | Parenteral Nutrition Support for Patients With Pancreatic Cancer | completed | Phase 2 | 32 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00498407 | A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 16 | Clavis PharmaINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00288925 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | completed | Phase 1 / Phase 2 | 30 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00102752 | Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer | completed | Phase 1 / Phase 2 | 47 | Threshold PharmaceuticalsINDUSTRY | 2 | Apr 30, 2009 | clinicaltrials |
| NCT00102700 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 2 | 66 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00290966 | Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 610 | SanofiINDUSTRY | 0 | Apr 29, 2009 | clinicaltrials |
| NCT00123851 | Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | completed | Phase 2 | 54 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00215462 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00234416 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00242788 | IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00094965 | Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function(FOLFOX4) | completed | Phase 2 | 43 | SanofiINDUSTRY | 1 | Mar 30, 2009 | clinicaltrials |
| NCT00153998 | Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) | completed | Phase 2 | 135 | Technische Universität DresdenOTHER | 2 | Feb 27, 2009 | clinicaltrials |
| NCT00422773 | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 21 | Technische Universität DresdenOTHER | 1 | Feb 27, 2009 | clinicaltrials |
| NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)(P2) | completed | Phase 2 | 46 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00197444 | Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | completed | Phase 2 | 33 | Hamamatsu UniversityOTHER | 1 | Feb 20, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 7, 2009source: clinicaltrials